1. Home
  2. PLAB vs AGIO Comparison

PLAB vs AGIO Comparison

Compare PLAB & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$29.33

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.32

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
AGIO
Founded
1969
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
PLAB
AGIO
Price
$29.33
$28.32
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
$44.33
$38.88
AVG Volume (30 Days)
1.8M
686.7K
Earning Date
05-27-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
9.09
N/A
EPS
0.74
N/A
Revenue
$535,276,000.00
$43,011,000.00
Revenue This Year
$6.70
$76.75
Revenue Next Year
$4.96
$170.73
P/E Ratio
$42.59
N/A
Revenue Growth
18.77
N/A
52 Week Low
$18.04
$22.24
52 Week High
$56.00
$46.00

Technical Indicators

Market Signals
Indicator
PLAB
AGIO
Relative Strength Index (RSI) 27.17 49.15
Support Level $21.52 $26.75
Resistance Level $38.00 $29.49
Average True Range (ATR) 2.58 1.30
MACD -2.30 0.03
Stochastic Oscillator 0.22 44.13

Price Performance

Historical Comparison
PLAB
AGIO

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: